Purchase Order 75F40120P00680
- Not listed
- This firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories. The $84,150 contract is for services to further elucidate the antimicrobial resistance pharmacogenetic relationships for select organisms and drug/drug classes, in order to advance regulatory science and public health. The work supports the FDA's efforts to address critical challenges...
- This is a $89,187.11 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories. The contract is for the evaluation of the relationship between phenotypic and molecular measures of antimicrobial resistance, and the development of a consultation report. This contract is not associated with a set-aside program. JMI Laboratories is a microbiology specialist company that provides a wide...
- This federal contract award is for antimicrobial resistance laboratory services with the Food and Drug Administration (FDA). The $1,122,383.45 definitive contract, with a firm fixed price, was awarded to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, a for-profit Subchapter S Corporation. The contract is an option exercise and contract officer representative change to an existing contract. JMI Laboratories is a microbiology specialist company that provides a...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $14,311 firm fixed-price delivery order to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, on July 22, 2019. This task order, designated Task A06, requires JMI Laboratories to determine the in vitro minimum inhibitory concentration (MIC) of a candidate antimicrobial product against a panel of Listeria monocytogenes clinical isolates. The work will be performed in North Liberty, Iowa, with...
- Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, was awarded a $76,000 delivery order on January 11, 2019, under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle. The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, funded this civilian contract to conduct in vitro assessments of antimicrobial activity against bacterial species....
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $570K delivery order to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, for determination of the in vitro inhibitory effect of experimental antibacterial substances against bacterial pathogens. The firm fixed-price contract was awarded on May 23, 2024, with an ultimate completion date of May 22, 2025, and will be performed in North Liberty, Iowa. This award falls under the In Vitro...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $981.3k to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, on June 21, 2019. This task order, designated A02, falls under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle and supports screening of natural product libraries for antimicrobial activity. The contract utilizes cost-plus-fixed-fee...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $195.7K delivery order to Element Materials Technology Iowa City Inc., operating as JMI Laboratories, for in vitro screening of antibacterial activity against public health disease pathogens. The contract, which was awarded on April 21, 2022, with an ultimate completion date of May 1, 2023, is structured as a firm fixed-price delivery order under the In Vitro Assessments of Antimicrobial Activity (IVAAA)...
- Element Materials Technology Iowa City Inc., operating as JMI Laboratories, was awarded a delivery order valued at $193,325 by the National Institute of Allergy and Infectious Diseases (NIAID) on August 31, 2023. The contract, which will be completed by August 30, 2024, requires the contractor to determine the in vitro minimal inhibitory concentration (MIC) of candidate products against a panel of Neisseria gonorrhoeae isolates. This delivery order was issued under the In Vitro Assessments of...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order valued at fifteen thousand twenty-six dollars ($15,026) to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, to test the in vitro antimicrobial activity of eighteen purified natural products identified from the National Cancer Institute's pre-fractionated natural product library as having potential antimicrobial properties....
The Department of Health and Human Services Food and Drug Administration awarded a $148,940 firm-fixed-price purchase order contract to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, to conduct research on elucidating antimicrobial resistance pharmacogenetic relationships for organisms and drug/drug classes of critical/serious concern. This work is intended to advance regulatory science and public health. The contract, which has a completion date of June 30, 2022, was set aside for small businesses. JMI Laboratories is a microbiology specialist company that provides a range of antimicrobial resistance testing and research services through federal contract awards from agencies like the FDA, National Institutes of Health, and National Cancer Institute. These have included conducting interlaboratory studies, performing in vitro inhibitory effect determinations, and analyzing antimicrobial resistance pharmacogenetic relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 5/12/22 | |
| Not listed | Not listed | $148.9k | 9/20/20 |